Protease-activated receptor 1 in the pathogenesis of cystic fibrosis

Background The most common cause of death in those with cystic fibrosis (CF) is respiratory failure due to bronchiectasis resulting from repeated cycles of respiratory infection and inflammation. Protease-activated receptor 1 (PAR1) is a cell surface receptor activated by serine proteases including...

Full description

Saved in:
Bibliographic Details
Main Authors: Sarath Ranganathan, Philip Sutton, Sophie Day, Poshmaal Dhar, Kristy Azzopardi, Muhammad A Saeed, Sohinee Sarkar, Jia-Xi Han
Format: Article
Language:English
Published: BMJ Publishing Group 2025-01-01
Series:BMJ Open Respiratory Research
Online Access:https://bmjopenrespres.bmj.com/content/12/1/e002960.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832592580462772224
author Sarath Ranganathan
Philip Sutton
Sophie Day
Poshmaal Dhar
Kristy Azzopardi
Muhammad A Saeed
Sohinee Sarkar
Jia-Xi Han
author_facet Sarath Ranganathan
Philip Sutton
Sophie Day
Poshmaal Dhar
Kristy Azzopardi
Muhammad A Saeed
Sohinee Sarkar
Jia-Xi Han
author_sort Sarath Ranganathan
collection DOAJ
description Background The most common cause of death in those with cystic fibrosis (CF) is respiratory failure due to bronchiectasis resulting from repeated cycles of respiratory infection and inflammation. Protease-activated receptor 1 (PAR1) is a cell surface receptor activated by serine proteases including neutrophil elastase, which is recognised as a potent modulator of inflammation. While PAR1 is known to play an important role in regulating inflammation, nothing is known about any potential role of this receptor in CF pathogenesis.Methods PAR1 (PAR1-/-) and intestinal-corrected CFTR (Cftr-/-) deficient mice were crossed to generate double knock-out (DKO) mutants lacking both PAR1 and CFTR, as well as matching sibling single mutant and wildtype (WT) littermate controls. Mice were weighed weekly to 15 weeks of age; then, the lungs and intestines were examined.Results Cftr-deficient mice gained body weight at a significantly slower rate than WT controls and presented with no lung inflammation, but had increased weights of their ilea and proximal colons. DKO mice (lacking both CFTR and PAR1) gained body weight at a similar rate to Cftr-/- mice but only gained weight in their proximal colons. Weight gain in the ilea of Cftr-/- but not DKO mice was associated with increased ileal levels in the pro-inflammatory cytokine interleukin (IL)-6.Conclusions This study provides the first evidence of PAR1 contributing to the pathological effects of Cftr deficiency in the intestine and suggests a possible effect of PAR1 on the regulation of IL-6 in CF pathogenesis.
format Article
id doaj-art-8d8088cffcb644dfb46d18e31d1a00c3
institution Kabale University
issn 2052-4439
language English
publishDate 2025-01-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open Respiratory Research
spelling doaj-art-8d8088cffcb644dfb46d18e31d1a00c32025-01-21T06:40:15ZengBMJ Publishing GroupBMJ Open Respiratory Research2052-44392025-01-0112110.1136/bmjresp-2024-002960Protease-activated receptor 1 in the pathogenesis of cystic fibrosisSarath Ranganathan0Philip Sutton1Sophie Day2Poshmaal Dhar3Kristy Azzopardi4Muhammad A Saeed5Sohinee Sarkar6Jia-Xi Han7Murdoch Children`s Research Institute, Parkville, Victoria, AustraliaMurdoch Children`s Research Institute, Parkville, Victoria, AustraliaMurdoch Children`s Research Institute, Parkville, Victoria, AustraliaMurdoch Children`s Research Institute, Parkville, Victoria, AustraliaMurdoch Children`s Research Institute, Parkville, Victoria, AustraliaMurdoch Children`s Research Institute, Parkville, Victoria, AustraliaMurdoch Children`s Research Institute, Parkville, Victoria, AustraliaMurdoch Children`s Research Institute, Parkville, Victoria, AustraliaBackground The most common cause of death in those with cystic fibrosis (CF) is respiratory failure due to bronchiectasis resulting from repeated cycles of respiratory infection and inflammation. Protease-activated receptor 1 (PAR1) is a cell surface receptor activated by serine proteases including neutrophil elastase, which is recognised as a potent modulator of inflammation. While PAR1 is known to play an important role in regulating inflammation, nothing is known about any potential role of this receptor in CF pathogenesis.Methods PAR1 (PAR1-/-) and intestinal-corrected CFTR (Cftr-/-) deficient mice were crossed to generate double knock-out (DKO) mutants lacking both PAR1 and CFTR, as well as matching sibling single mutant and wildtype (WT) littermate controls. Mice were weighed weekly to 15 weeks of age; then, the lungs and intestines were examined.Results Cftr-deficient mice gained body weight at a significantly slower rate than WT controls and presented with no lung inflammation, but had increased weights of their ilea and proximal colons. DKO mice (lacking both CFTR and PAR1) gained body weight at a similar rate to Cftr-/- mice but only gained weight in their proximal colons. Weight gain in the ilea of Cftr-/- but not DKO mice was associated with increased ileal levels in the pro-inflammatory cytokine interleukin (IL)-6.Conclusions This study provides the first evidence of PAR1 contributing to the pathological effects of Cftr deficiency in the intestine and suggests a possible effect of PAR1 on the regulation of IL-6 in CF pathogenesis.https://bmjopenrespres.bmj.com/content/12/1/e002960.full
spellingShingle Sarath Ranganathan
Philip Sutton
Sophie Day
Poshmaal Dhar
Kristy Azzopardi
Muhammad A Saeed
Sohinee Sarkar
Jia-Xi Han
Protease-activated receptor 1 in the pathogenesis of cystic fibrosis
BMJ Open Respiratory Research
title Protease-activated receptor 1 in the pathogenesis of cystic fibrosis
title_full Protease-activated receptor 1 in the pathogenesis of cystic fibrosis
title_fullStr Protease-activated receptor 1 in the pathogenesis of cystic fibrosis
title_full_unstemmed Protease-activated receptor 1 in the pathogenesis of cystic fibrosis
title_short Protease-activated receptor 1 in the pathogenesis of cystic fibrosis
title_sort protease activated receptor 1 in the pathogenesis of cystic fibrosis
url https://bmjopenrespres.bmj.com/content/12/1/e002960.full
work_keys_str_mv AT sarathranganathan proteaseactivatedreceptor1inthepathogenesisofcysticfibrosis
AT philipsutton proteaseactivatedreceptor1inthepathogenesisofcysticfibrosis
AT sophieday proteaseactivatedreceptor1inthepathogenesisofcysticfibrosis
AT poshmaaldhar proteaseactivatedreceptor1inthepathogenesisofcysticfibrosis
AT kristyazzopardi proteaseactivatedreceptor1inthepathogenesisofcysticfibrosis
AT muhammadasaeed proteaseactivatedreceptor1inthepathogenesisofcysticfibrosis
AT sohineesarkar proteaseactivatedreceptor1inthepathogenesisofcysticfibrosis
AT jiaxihan proteaseactivatedreceptor1inthepathogenesisofcysticfibrosis